LBE-01

LBE-01
Product Description

The first product is an emergency auto-injectable pen (e.g., LBE-01 Epinephrine Auto-Injector). It is designed for the treatment of severe allergic reactions and cardiac arrest emergencies, available in two versions: adult (0.3 mg/ml) and pediatric (0.15 mg/ml). The device offers a user-friendly two-step operation and features auditory-visual feedback. For safety, it incorporates a concealed needle and a unique self-locking mechanism to prevent needle exposure and secondary injuries. From raw material selection to product manufacturing, LBE-01 strictly complies with PIC/S, ISO 9001, and cGMP regulations, ensuring comprehensive safety and reliability.

LBE Pharma Tech. Co., Ltd

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Pharmaceutical Company (generic finished products)

LBE Pharma Tech. Co., Ltd

  • Country/Region:
    China
  • On CPHI since:
    2025
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
CMO/CDMO
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Manufacturer
Pharmaceutical Company (generic finished products)